Clinical Trials in Sondrio, Italy
5 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 2
Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer
Ovarian Cancer
ARCAGY/ GINECO GROUP390 enrolled88 locationsNCT05183984
Recruiting
Phase 3
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Colorectal Neoplasms
Seagen, a wholly owned subsidiary of Pfizer400 enrolled382 locationsNCT05253651
Recruiting
Neurosurgical Outcome Network
DepressionTrigeminal NeuralgiaObsessive-Compulsive Disorder+20 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta4,500 enrolled27 locationsNCT06724029
Recruiting
Phase 3
Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi
Follicular Lymphoma
Fondazione Italiana Linfomi - ETS190 enrolled48 locationsNCT05929222
Recruiting
Prospective Observational Study Based on a Cohort of Geriatric Patients With Hip Fracture Treated in the Centers Belonging to the GIOG Group
Older PatientsHip FracturesComprehensive Geriatric Assessment
University of Milano Bicocca7,000 enrolled11 locationsNCT05150249
Recruiting
Diagnosis and Treatment of Late Neurological Ischemic Deficit in Patients Suffering From Subarachnoid Hemorrhage.
Aneurysmal subarachnoid haemorrhageDelayed Ischemic Neurological Deficit
Fondazione IRCCS San Gerardo dei Tintori1,400 enrolled33 locationsNCT06804421